Background: Freezing of gait, a common pathological gait in Parkinson's disease, is progressive with the progression of the disease. It is an important risk factor for patients to fall easily, lose their independent living ability and decline their quality of life. The treatment of Parkinson's disease with freezing of gait is very difficult, and the effect of medicine and operation is not ideal. Music exercise therapy is a kind of treatment technology that can change the behavior, emotion and physiological activity of patients by listening to music at the same time of exercise therapy. In recent years, music exercise therapy has been widely used in motor disorders and neurological diseases, and has achieved remarkable results. The small sample study in the early stage of this research group initially found that music exercise therapy can improve the freezing of gait of Parkinson's patients and improve the quality of life of patients. The overall purpose of this experiment is to expand the sample size to further evaluate the clinical effect of music exercise therapy on freezing of gait of Parkinson's patients.Methods/design: This randomized controlled trial will evaluate the clinical efficacy of music exercise therapy in improving the freezing of gait of Parkinson's patients. The patients will receive music exercise therapy, exercise therapy without music and routine rehabilitation therapy at random. We will recruit 81 inpatients of Parkinson's who meet the trial criteria to observe the changes of gait and limb motor function after 4 weeks of intervention. The first evaluation index is to use three-dimensional gait analysis system to evaluate the change of patients' gait. The second evaluation index includes limb function, activity of daily living and fall risk assessment.Discussion: Our aim is to evaluate the efficacy of music exercise therapy in the treatment of Parkinson's patients with freezing of gait. This result will provide more evidence for the clinical application of this therapy in the future.Trial registration: The trial has been registered at the Chinese Clinical Trial Registry (http://www.chictr.org.cn) on September 20, 2019. Registration number: ChiCTR1900026063